Showing results (81-90 of 125) with videos related to
Sort By:
Pageof 13
Neuro-Oncology|January 18, 2020
Neurologic and oncologic features of Erdheim-Chester disease: a 30-patient seriesAnkush Bhatia, Vaios Hatzoglou, Gary Ulaner, et al.Blood|March 31, 2026
International Expert Recommendations for the Diagnosis and Treatment of Malignant Histiocytic NeoplasmsGaurav Goyal, Oussama Abla, John K C Chan, et al.Blood Advances|March 29, 2019
A scale for patient-reported symptom assessment for patients with Erdheim-Chester diseaseEli L Diamond, Anne S Reiner, Justin J Buthorn, et al.Blood|May 18, 2017
Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adultsPaul Milne, Venetia Bigley, Chris M Bacon, et al.Cancer Discovery|February 8, 2020
Pan-Cancer Efficacy of Vemurafenib in BRAF V600-Mutant Non-Melanoma CancersVivek Subbiah, Igor Puzanov, Jean-Yves Blay, et al.Journal of the Neurological Sciences|October 28, 2022
Predictors of overlapping autoimmune disease in Neuromyelitis Optica Spectrum disorder (NMOSD): A retrospective analysis in two inner-city hospitalsMilena Rodriguez Alvarez, Aveena Gurung, Vinodkumar Velayndhan, et al.Blood|May 4, 2018
Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes diseaseOussama Abla, Eric Jacobsen, Jennifer Picarsic, et al.Blood Advances|October 24, 2023
Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasmsBenjamin H Durham, Oshrat Hershkovitz-Rokah, Omar Abdel-Wahab, et al.Blood|May 23, 2014
Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester diseaseEli L Diamond, Lorenzo Dagna, David M Hyman, et al.Neurology(R) Neuroimmunology & Neuroinflammation|October 23, 2025
Refractory Tumorous and Neurodegenerative Histiocytosis Treated With Intra-Arterial ChemotherapyAlexander Ramos, Andrew L A Garton, Jared Knopman, et al.Pageof 13